Orbis

is a Denmark-based drug discovery platform that researches and develops oral macrocycle biologic drugs for the treatment of various diseases...
Read more
Orbis CEO: Morten Graugaard

CEO

Morten Graugaard

CEO Approval Rating

- -/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$120.9M

Orbis Competitors

1BenevolentAI
2Causaly
3Biorelate
4Exscientia
5Atomwise
6D2L Pharma Research
7Recursion
8Innoplexus
9Intelligentsia Worldwide Ltd.
10XtalPi